Abstract
Many of the advances in our knowledge about liver disease have followed the wider use of liver biopsy and development of new techniques such as ultrasonography and computed tomography. Nevertheless, blood tests remain the first investigations in the assessment of liver dysfunction. None of the tests is entirely specific, and interpretation usually depends on examination of a constellation of results together with the clinical presentation. There is no true ‘liver function test’.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Killenberg PF, Stevens RD, Wilderman RF, Wilderman NM. The laboratory method as a variable in the interpretation of serum bilirubin fractionisation. Gastroenterology 1980; 78: 1011–5
Skillen AW, Fifield RD, Sheraidah GS. Serum alkaline phosphatase isoenzyme patterns in disease. Clin Chim Acta 1972; 40: 21–5
Burrows S, Feldman W, McBride F. Serum gamma-glutamyl transpeptidase. Am J Clin Pathol 1975; 65: 311–4
Van Wates L, Lieber C. Glutamate dehydrogenase: a reliable marker of liver cell necrosis in the alcoholic. Br Med J 1977; 2: 1508–10
Adachi Y, Horii K, Takahashi Y, Tanahata H, Ohba Y, Yamamoto T. Serum glutathione S-transferase activity in liver diseases. Clin Chim Acta 1980; 106: 243–55
References
Ferraris R, Fiorentini MT, Galatola G, Rolfo P, De la Pierre M. Diagnostic value of serum immunoreactive conjugated cholic or chenodeoxycholic acids in detecting hepato-biliary diseases: comparison with levels of 3 alpha-hydroxy bile acids determined enzymatically and with routine liver tests. Dig Dis Sci 1987; 32: 817–23
Yamanishi Y, Kishimoto Y, Kawasaki H, Hirayama C, Ikawa S. Oral ursodeoxycholic acid tolerance test in patients with digestive disease. Gastroenterol Jpn 1981; 16: 472–7
Mannes GA, Thieme C, Stellard F, Wang T, Sauerbruck T, Paumgartner G. The prognostic significance of serum bile acids in cirrhosis. Hepatology 1986; 6: 50–3
Luey KL, Heaton KW. Bile acid clearance in liver disease. Gut 1979; 20: 1083–7
Engelking LR, Dasher CA, Hirschowitz BI. Within-day fluctuation in serum bile-acid concentration among normal control subjects and patients with hepatic disease. Am J Clin Pathol 1980; 73: 196–201
References
Scharshmidt BF, Blankaert N, Farina FA, Kabra PM, StaffordBE, Weisiger RA.. Measurement of serum bilirubin and its mono- and diconjugates: applicability to patients with hepatobiliary disease. Gut 1982; 23: 643–9
Coken JA, Kaplan MM. The SGOT/SGPT ratio — an indicator of alcoholic liver disease. Dig Dis Sci 1979; 24: 835–8
Chalmers DM, Rinsler MG, MacDermott S, Spicer CC, Levi AJ. Biochemical and haematological indicators of excessive alcohol consumption. Gut 1981; 22: 992–6
Nalpas B, Vassault A, Charpin S, Lacour B, Berthelot P. Serum mitochondrial (m) AST as a marker of chronic alcoholism: diagnostic volume and interpretation in a liver unit. Hepatology 1986; 4: 608–14
Penn R, Worthington DJ. Is serum gamma-glutamyltransferase a misleading test? Br Med J 1983; 286: 531–5
Skinner HA, Holt S, Sheu WJ, Israel Y. Clinical versus laboratory detection of alcohol abuse: the alcohol clinical index. Br Med J 1986; 292: 1703–8
Solberg HE, Skrede S, Blomhoff JP. Diagnosis of liver diseases by laboratory results and discriminant analysis. Scand J Clin Lab Invest 1975; 35: 713–21
References
Berg PA, Klein R, Lindenborn-Fotinos J et al. ATP-ase-associated antigen (M2); marker antigen for serological diagnosis of PBC. Lancet 1982; 2: 1423–6
Doniach D, Walker GJ. Mitochondrial antibodies (AMA). Gut 1974; 15: 664–8
Chen D-S, Sung J-L, Sheu J-C. et al. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 1984; 86: 1404–9
References
Lavarini C, Farci P, Chiaberge E, Veglio V, Giacobbi D, Bedarida G, Susani G, Toti M, Almi P, Caporaso N, Del Vecchio Blanco C, Rizzetto M. IgM antibody against hepatitis B core antigen (IgM anti-HBc): diagnostic and prognostic significance in acute HBsAg positive hepatitis. Br Med J 1983; 287: 1254–6
Blum HE, Haase AT, Vyas GN. Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet 1984; 771–4
Wantzin P, Nielsen JO, Tygstrup N, Soerensen H, Dybkjaer E. Screening of Danish blood donors for hepatitis B surface antigen using a third generation technique. Br Med J 1985; 291: 780–2
Hoofnagle JH. Type D hepatitis and the hepatitis delta antigen. In Thomas HC, Jones EA (eds.) Recent Advances in Hepatology 1986, Edinburgh: Churchill Livingstone, pp. 73–92
Colombo M, Cambieri R, Rumi MG, Ronchi G, Del Ninno E, De Franchis R. Longterm delta superinfection in HBsAg carriers and its relationship to the course of chronic hepatitis. Gastroenterology 1983; 85: 235–9
Fagan EA, Williams R. Serological responses to HBV infection. Gut 1986; 27: 858–67
Lindsay KL, Nizze JA, Koretz R, Gitnick E. Diagnostic usefulness of testing for anti-HBc IgM in acute hepatitis B. Hepatology 1986; 6: 1325–8
Arico S, Aragona M, Rizzetto M et al. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers. Lancet 1985; 2: 356–8
Aragona M, Caredda F, Lavarini C, Farci P, Macagno S, Crivelli O, Maran E, Purcell RH, Rizzetto M. Serological response to the hepatitis delta virus in hepatitis D. Lancet 1987; 1: 478–80
Tabor E. The three viruses of non-A, non-B hepatitis. Lancet 1985; 1: 743–5
References
Javitt NB. Clinical and experimental aspects of sulphobromophthalein and related compounds. Progr Liver Dis 1970; 3: 110–7
Brügmann E, Towe J. Indocyanine green clearance in a liver function test. Mater Med Pol 1974; 6: 123–6
Grace ND, Castell DO, Wennar MH. A comparison of the oral fructose and ammonia tolerance tests in cirrhosis. Arch Int Med 1969; 124: 330–6
Murew J, Kierulf P. The intravenous galactose test as indication of the extent of fibrosis in patients with cirrhosis of the liver. Scand J Gastroenterol 1969; 4: 453–6
Lewis KO, Nicholson G, Lance P, Paton A. Aminopyrine breath test in alcoholic liver disease and in patients on enzyme inducing drugs. J Clin Pathol 1977; 30: 1040–3
Saunders JB, Lewis KO, Paton A. Early diagnosis of alcoholic cirrhosis by the aminopyrine breath test. Gastroenterology 1980; 79: 112–4
Felding RH, Christensen RF, Lindahl F. Ammonia tolerance test. Scand J Gastroenterol 1984; 19: 365–8
References
Owens D, Sherlock S. The diagnosis of Gilbert’s syndrome: Role of the reduced calorie intake test. Br Med J 1973; 3: 559–63
Felsher BF, Carpoi NM. Calorie intake in unconjugated hyperbilirubinaemia. Gastroenterology 1975; 69: 42–7
Halliday JW, Russo A, Collishaw J, Powell LW. Serum ferritin in the diagnosis of early haemochromatosis: A study of 43 families. Lancet 1977; 2: 621–3
Finch CA, Huebers H. Perspectives in iron metabolism. N Engl J Med 1982; 306: 1520–9
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Bateson, M.C., Bouchier, I.A. (1988). Liver biochemistry. In: Clinical Investigations in Gastroenterology. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2633-2_11
Download citation
DOI: https://doi.org/10.1007/978-94-009-2633-2_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7688-3
Online ISBN: 978-94-009-2633-2
eBook Packages: Springer Book Archive